Healthy Life

An ageing population is becoming one of the most significant social transformations of the 21st century. Russia has set an ambitious goal of joining the club of ‘80+’ countries, to increase life expectancy to 80 years by 2030. Only 20% of our health is dependent on our genes; everything else consists of biological factors that we can influence. At the same time, not everything and not always depends on the state alone. Preventive care, timely diagnosis, adopting gold standards of treatment, healthy lifestyle, responsible attitude to one's own health are key elements of preventive medicine, which not only make it possible to achieve the goal of 80+, but also significantly reduce the government’s expenditures on the treatment of diseases which can and need to be prevented. Today we have to talk about the quality of life, not just its expectancy. Only an increase in the duration of a quality life can affect economic growth. For the first time the state programme features such indicator as ‘an increase in a quality life expectancy’. What are the advantages and disadvantages of the modern approaches of preventive medicine? Which government programmes are aimed at achieving the 80+ goal? What does science know about preventing age-related changes?

Moderator
Natalya Popova, First Deputy General Director, Innopraktika

Natalya Popova

First Deputy General Director, Innopraktika

Panellists
Olga Tkacheva, Director, Russian Gerontology Clinical Research Centre (RGNKC)
Svetlana Trofimova, President, Russian Society of Anti-Ageing Medicine
Vladimir Khavinson, Director, St. Petersburg Institute of Bioregulation and Gerontology

Olga Tkacheva

Director, Russian Gerontology Clinical Research Centre (RGNKC)

Olga Tkacheva graduated with honours from S.M. Kirov Gorky State Medical Institute majoring in General Medicine and the therapy internship in S.M. Kirov Gorky State Medical Institute. In 1993, Olga Tkacheva was awarded the scientific degree of Candidate of Medical Sciences, in 1999 – Doctor of Medical Sciences. In 2006, she earned the title of professor. Ms Tkacheva has 32 years of clinical work experience and 28 years of teaching under her belt.
From 2013 to 2018 – Senior Geriatrician of the Ministry of Healthcare of the Russian Federation. From 2015 – present – contracted Chief Geriatrician of the Ministry of Healthcare of the Russian Federation and Director of Russian Clinical Research Centre for Gerontology. She is the author of more than 300 scientific publications, 11 monographs, national guidelines, has one certificate and three patents for inventions.
She headed the working groups and was a member of expert committees on the preparation of national guidelines ‘Diagnosis and treatment of hypertension’, the recommendations on diagnosis and treatment of hypertension in pregnant women, national guidelines on diagnosis and treatment of cardiovascular diseases during pregnancy, guidelines on general risk reduction of disease and complications in women, practical guidelines on the use of hormone replacement therapy in peri- and postmenopausal women, national guidelines ‘Prevention of chronic non-communicable diseases’, guidelines for physicians ‘Basic Principles of the prevention and treatment of thrombosis in tables and charts’, guidelines ‘Follow-up monitoring of patients with chronic non-communicable diseases and high-risk patients’.
Olga Tkacheva’s scientific research focused on the mechanisms and patterns of the heart and blood vessels ageing and their correlation with cellular replicative ageing, the issues of the age-related metabolic disorders, prevention and treatment of age-related diseases and geriatric syndromes.
She advised on 20 candidate and five doctoral theses.
She is the president of the National Public Organization ‘Russian Association of Gerontologists and Geriatricians’, member of the National Public Organization ‘Russian Society for the Prevention of Non-Communicable Diseases’, National Public Organization ‘Russian Society of Cardiology’, National Organization ‘Russian Medical Society on Arterial Hypertension’, National Medical Society of Preventive Cardiology, European Society of Cardiology, European Geriatric Medicine Society.
She is a member of the editorial board of medical journals ‘Rational Pharmacotherapy in Cardiology’, ‘Preventive Medicine’, ‘Clinical Gerontology’, ‘Archives of Internal Medicine’, ‘Medical Care’, ‘Women’s Health Issues’, ‘Russian Open Medical Journal’, ‘Bulletin of the Ivanovo Medical Academy’.

Svetlana Trofimova

President, Russian Society of Anti-Ageing Medicine

Director General of the Clinic of predictive medicine “The Tree of Life” of Saint Petersburg Institute of Bioregulation and Gerontology; President of the Russian Anti-Aging Medicine Society from 2013,General Secretary of the European Society of Preventive, Regenerative and Anti-Aging medicine (ESAAM) from 2015. General Secretary of the World Council for Preventive, Regenerative and Anti-Aging medicine (WOCPM) from 2016. Prof. Svetlana Trofimova is one of the leading experts in the field of anti-aging medicine. She is the author of more than 150 scientific papers (monographs, workbooks, articles) and 4 patents. She was the thesis adviser for 5 obtained theses. TV host of the program "Secrets of longevity" ("The most important") on the channel "Russia". Author of the popular science books “Immortality tomorrow?” published in Monaco (2015) and Singapore (2016) and “What prevents us from living up to 100 years? Discussions about longevity”

Vladimir Khavinson

Director, St. Petersburg Institute of Bioregulation and Gerontology

Director of the Saint-Petersburg Institute of Bioregulation and Gerontology, Head of the Gerontology and Geriatrics Dpt. at the NW State Medical University, Main Specialist in Gerontology And Geriatrics of the Governments of Saint Petersburg and Leningrad Region, Member of the Russian Academy of Sciences and Ukrainian Academy of Medical Sciences, Vice–President of the Gerontological Society of the Russian Academy of Sciences, Past President of the European Association of Gerontology and Geriatrics.
Since 1971 V. Khavinson has been engaged in studying the role of peptides in regulation of the mechanisms of ageing, design, preclinical and clinical studies of new peptide geroprotectors. His 35-year long investigations resulted in elaboration of a method for complex application of peptide bioregulators to slow down ageing and increase average life span. 6 peptide pharmaceuticals and 64 food supplements developed by V. Khavinson have been introduced into clinical practice.
V. Khavinson is the author of over 800 scientific publications with the major achievements summarized in his books “Peptides and Ageing” (NEL, 2002) and “Gerontological aspects of genome peptide regulation” (Karger AG, 2005). He is the author of 205 Russian and International patents. In 2009 the Institute headed by him was designated an IAGG Collaborating Centre. In 2010 the Institute was given a Special Consultative Status of the UN ECOSOC.

Front row participants
David Verdesi, Anthopologist; author of the Superhuman methodology based on the research of world religions and the latest discoveries in quantum physics and neurobiology
Maria Grudina, Co-Founder, First Line Health Care Resort
Yulia Markova, Managing Director, Johnson & Johnson Medical Devices Russia and CIS

David Verdesi

Anthopologist; author of the Superhuman methodology based on the research of world religions and the latest discoveries in quantum physics and neurobiology

Maria Grudina

Co-Founder, First Line Health Care Resort

Maria Grudina graduated with honors from the St. Petersburg University of Economics and Finance in 2008 with a major in World Economics. In 2014, she completed the program “Management in the international hospitality industry” at the Russian-Swiss business school SWISSAM.

In 2018-2019, she completed the Leadership Development Program at the Skolkovo Business School.

Maria has been working in the field of real estate and hospitality for more than 10 years, and for 3 years in healthcare.

Since 2009, she worked as Executive
Director of the non-profit organization called “Real Estate Market Consumer Center” and was the CEO of the “Life” hotel.

In 2016, Maria began her work with the “Pioneer” group of companies, and founded the project “First Line. Health Care Resort ”. Maria is developing this project to the present. The launch of the resort took place in January 2018. The official opening with the participation of the Governor of St. Petersburg was held on the Day 0 of the Economic Forum on May 23, 2018. The project became the leader of preventive rehabilitation in St. Petersburg and Russia in a short time. As part of the work of the First Line, in November 2018 the first international conference on prevent age in St. Petersburg was held with the support of the SPB Government. More than 3,800 people have attended health improvement programs at the resort.

In 2019, she received the award “Influential Women of St. Petersburg” from Business Petersburg, and won the Sobaka.ru magazine award “TOP 50.Most famous people of St. Petersburg”.

Maria is married with three children, speaks English and French, enjoys Pilates and healthy lifestyle. She has written a short stories book, and studies the methodology of thinking.

Yulia Markova

Managing Director, Johnson & Johnson Medical Devices Russia and CIS

Yulia holds a Bachelor’s degree in Nursing Management and a Post-graduate degree in Public Health and Healthcare Administration from the Moscow Medical Academy. Yulia equally holds an executive MBA in General Management from the Harvard Business School.

Yulia began her career at Johnson & Johnson Russia back in 1999 and held positions in the sales and marketing departments with an increasing area of responsibility, including managing large business units within medical devices sector. In 2013 Yulia was assigned the role of Managing Director Johnson & Johnson Medical Devices Russia & CIS. From November 21st 2017 Yulia is a Chairperson of the Board of Directors of International Medical Device Manufacturers Association.

Yulia was included into RBC’s top-list of women who are successfully leading the largest companies operating in Russia two years in a row.